{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:49:24Z","timestamp":1790495364613,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"name":"The French National Institute for Health and Medical Research\u2014France Recherche Nord&Sud Sida-HIV H\u00e9patites"},{"name":"the Instituto Superiore di Sanit\u00e0\u2014Rome, by the EU under the Sixth Framework programme","award":["LSHP-CT-2006-037570"],"award-info":[{"award-number":["LSHP-CT-2006-037570"]}]},{"name":"Gilead Sciences, Janssen Pharmaceuticals and Merck Laboratories"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1093\/jac\/dkv427","type":"journal-article","created":{"date-parts":[[2015,12,25]],"date-time":"2015-12-25T02:43:53Z","timestamp":1451011433000},"page":"1056-1062","source":"Crossref","is-referenced-by-count":24,"title":["Antiretroviral resistance at virological failure in the NEAT 001\/ANRS 143 trial: raltegravir plus darunavir\/ritonavir or tenofovir\/emtricitabine plus darunavir\/ritonavir as first-line ART"],"prefix":"10.1093","volume":"71","author":[{"given":"S.","family":"Lambert-Niclot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schwimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. F.","family":"Perno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Plettenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Blaxhult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wittkop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Calvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Raffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,24]]},"reference":[{"key":"2016031409382588000_71.4.1056.1","unstructured":"European AIDS Clinical Society. European AIDS Clinical Society Guidelines for the Treatment of HIV-infected Adults . European AIDS Clinical Society (EACS). http:\/\/www.eacsociety.org\/files\/guidelines-7.1-english.pdf ."},{"key":"2016031409382588000_71.4.1056.2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32830fe35e"},{"key":"2016031409382588000_71.4.1056.3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/QAI.0000000000000662","article-title":"Effect of cumulating exposure to abacavir on the risk of cardiovascular disease events in patients from the Swiss HIV Cohort Study","volume":"69","author":"Young","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2016031409382588000_71.4.1056.4","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328351f68f"},{"key":"2016031409382588000_71.4.1056.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066223"},{"key":"2016031409382588000_71.4.1056.6","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835192ae"},{"key":"2016031409382588000_71.4.1056.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61170-3"},{"key":"2016031409382588000_71.4.1056.8","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31828ace69"},{"key":"2016031409382588000_71.4.1056.9","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1084"},{"key":"2016031409382588000_71.4.1056.10","first-page":"138","article-title":"Update of the drug resistance mutations in HIV-1: December 2009","volume":"17","author":"Johnson","year":"2009","journal-title":"Top HIV Med Publ Int AIDS Soc USA"},{"key":"2016031409382588000_71.4.1056.11","first-page":"642","article-title":"Special Contribution 2014 Update of Drug Resistance Mutations in HIV-1","volume":"22","author":"Wensing","year":"2014","journal-title":"Top Antivir Med"},{"key":"2016031409382588000_71.4.1056.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2012.01060.x"},{"key":"2016031409382588000_71.4.1056.13","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000089"},{"key":"2016031409382588000_71.4.1056.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074609"},{"key":"2016031409382588000_71.4.1056.15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1089\/aid.2011.0275","article-title":"Lopinavir\/ritonavir combined with raltegravir or tenofovir\/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study","volume":"29","author":"Reynes","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2016031409382588000_71.4.1056.16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67399"},{"key":"2016031409382588000_71.4.1056.17","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-9-63"},{"key":"2016031409382588000_71.4.1056.18","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks052"},{"key":"2016031409382588000_71.4.1056.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70257-3"},{"key":"2016031409382588000_71.4.1056.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60918-1"},{"key":"2016031409382588000_71.4.1056.21","doi-asserted-by":"publisher","DOI":"10.1310\/hct1303-119"},{"key":"2016031409382588000_71.4.1056.22","doi-asserted-by":"publisher","DOI":"10.3390\/v6072858"},{"key":"2016031409382588000_71.4.1056.23","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834bbaa9"},{"key":"2016031409382588000_71.4.1056.24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01209-10"},{"key":"2016031409382588000_71.4.1056.25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu051"},{"key":"2016031409382588000_71.4.1056.26","unstructured":"Underwood MR , DeAnda F , Dorey D et al . Resistance post week 48 in ART-experienced, integrase inhibitor-na\u00efve subjects with dolutegravir (DTG) vs. raltegravir (RAL) in SAILING (ING111762). http:\/\/regist2.virology-education.com\/abstractbook\/2015_5.pdf ."},{"key":"2016031409382588000_71.4.1056.27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv049"},{"key":"2016031409382588000_71.4.1056.28","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks254"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/4\/1056\/6992834\/dkv427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T23:34:26Z","timestamp":1567467266000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkv427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,24]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,3,14]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1093\/jac\/dkv427"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv427","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,24]]}}}